4DMedical completes $150 million institutional placement
Filed with ASX · · 4 pages · English
Summary by 6ix AI
4DMedical Ltd. has announced the completion of an institutional placement to raise significant capital for its operations, specifically targeting the commercialization of its CT:VQ™ product in the U.S. The placement received strong support from both new and existing institutional investors, with commitments exceeding the placement size. The company aims to utilize the proceeds for sales, marketing, and research to enhance its product offerings and market presence.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from 4DMedical
- Trading Halt
- UC San Diego Health adopts CTVQ
- Cleveland Clinic adopts CTVQ
- 4DMedical secures regulatory approval for CTVQ in Canada
- 4DMedical secures $30.2 million with options underwrite
Later from 4DMedical
- 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
- Quarterly Activity Report and Appendix 4C
- University of Chicago Medicine adopts CTVQ
- Response to ASX Query Letter
- Appendix 4D and FY26 Half Year Report
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical